 39-year-old woman with severe hard-to-treat antifospholipid antibody syndrome, APS, was successfully treated with a combination therapy of plizmophoresis and rituximab, resulting in complete remission of skin lesions for over a year. This article was authored by Paraskevi Kokkalu, Jan Urchin, and Tobias Gohach.